Csa Medial, Inc.
Country not established
- Devices
- 1
What Csa Medial, Inc. makes
Csa Medial, Inc. manufactures the truFreeze System, a cryotherapy device used for tissue ablation and treatment of benign prostatic hyperplasia (BPH).
The truFreeze System is classified as a Class II medical device in the U.S. and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
truFreeze System Ref K160273
510(k) 510(k)
Frequently asked questions
How many devices does Csa Medial, Inc. have in the registry?
The registry currently lists 1 device for Csa Medial, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Csa Medial, Inc.'s devices?
Among its 1 most recently registered device, Csa Medial, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Csa Medial, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Csa Medial, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Csa Medial, Inc. in the registry?
The most recently registered devices listed for Csa Medial, Inc. include truFreeze System.